ArticleThe Korean journal of internal medicine2023

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet's disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study.

Seung Bum Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.